Literature DB >> 525228

Study of the renin-angiotensin system in essential hypertension.

I Tényi, M Németh, J Nemes, J Czimer.   

Abstract

320 patients with essential hypertension divided into three groups (minor, medium and major severty) were studied against 50 normal controls. Plasma renin activity (PRA) was estimated in case of normal and low Na intake, furthermore, of low Na intake in association with administration of chlorothiazide, in the recumbent position as well as at the end of 4-hr walk. The hypertensive group of medium severity (Group II) revealed a significant decrease in PRA, compared with the controls and with the hypertensive group of minor severity (Group I), in each period of observation. A significant increase of PRA in response to insulin hypoglycaemia was demonstrable in all three groups and in the controls, but the increase was of significantly lesser degree in Group II than either in the controls or in Group I. The plasma catecholamine concentrations were found lower in Group II than in the controls and in Group I. An elevation of the plasma catecholamine levels was demonstrable in response to insulin hypeglycaemia, but it was of lesser degree in Group II than a Group I and in the controls. The poor responsiveness of the RAS in Group II is attributed to an inadequate adrenergic activity and to an increased mean arterial pressure in that group, but the higher age of patients and longer duration of hypertensive disease, both characteristic of the group of medium severity, may also effect the renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 525228

Source DB:  PubMed          Journal:  Acta Med Acad Sci Hung        ISSN: 0001-5989


  1 in total

1.  Association of the polymorphism 12109g>A from the REN gene as a risk factor for preterm birth.

Authors:  Irám P Rodríguez-Sánchez; Stephania Suárez-Caro; Fernando Rivas-Solís; Iván Delgado-Enciso; María M Sánchez-Chaparro; Mayra A Gómez-Govea; Laura E Martínez-de-Villarreal; Laura L Valdez-Velazquez
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016 Oct-Dec       Impact factor: 1.636

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.